The global OTC cough, cold and allergy medicine market reached a valuation of US$ 36.92 Billion in 2021Y, and is likely to register a Y-o-Y growth rate of 5.0% in 2022, closing at US$ 38.96 Billion. Furthermore,…
The global OTC cough, cold and allergy medicine market reached a valuation of US$ 36.92 Billion in 2021Y, and is likely to register a Y-o-Y growth rate of 5.0% in 2022, closing at US$ 38.96 Billion. Furthermore,…